India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III …

There are a total of 30 vaccine candidates in India in various stages of development and testing. India's first CRISPR COVID-19 test developed by Tata …

To Read More, Please Visit Source

Related Articles

Back to top button